Lyka Labs Limited (LYKALABS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Lyka Labs Limited (LYKALABS) has a cash flow conversion efficiency ratio of 0.135x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs136.84 Million ≈ $1.48 Million USD) by net assets (Rs1.01 Billion ≈ $10.96 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see LYKALABS market cap overview for the company's overall valuation and market capitalisation.
Lyka Labs Limited - Cash Flow Conversion Efficiency Trend (2005–2025)
This chart illustrates how Lyka Labs Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Lyka Labs Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Lyka Labs Limited ranked by their cash flow conversion efficiency. Explore LYKALABS cash to earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Alset Ehome International Inc
NASDAQ:AEI
|
-0.063x |
|
Sunson Textile Manufacturer
JK:SSTM
|
0.006x |
|
VivoPower International PLC
NASDAQ:VVPR
|
0.221x |
|
Ruanyun Edai Technology Inc. Ordinary shares
NASDAQ:RYET
|
-0.058x |
|
Prevision Sanitaria Nacional Gestion SOCIMI S.A.
MC:YPSN
|
N/A |
|
EON Resources Inc.
NYSE MKT:EONR
|
-0.127x |
|
Candles Scandinavia AB Series B
ST:CANDLE-B
|
-0.085x |
|
Atlas Engineered Products Ltd
V:AEP
|
0.050x |
Annual Cash Flow Conversion Efficiency for Lyka Labs Limited (2005–2025)
The table below shows the annual cash flow conversion efficiency of Lyka Labs Limited from 2005 to 2025. View latest Lyka Labs Limited stock price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs1.04 Billion ≈ $11.20 Million |
Rs18.99 Million ≈ $205.41K |
0.018x | -29.41% |
| 2024-03-31 | Rs682.65 Million ≈ $7.38 Million |
Rs17.73 Million ≈ $191.78K |
0.026x | -86.75% |
| 2023-03-31 | Rs456.71 Million ≈ $4.94 Million |
Rs89.53 Million ≈ $968.19K |
0.196x | -96.66% |
| 2022-03-31 | Rs134.91 Million ≈ $1.46 Million |
Rs792.46 Million ≈ $8.57 Million |
5.874x | +1772.76% |
| 2021-03-31 | Rs-250.93 Million ≈ $-2.71 Million |
Rs88.11 Million ≈ $952.93K |
-0.351x | +0.32% |
| 2020-03-31 | Rs-151.11 Million ≈ $-1.63 Million |
Rs53.23 Million ≈ $575.71K |
-0.352x | -160.45% |
| 2019-03-31 | Rs457.59 Million ≈ $4.95 Million |
Rs266.66 Million ≈ $2.88 Million |
0.583x | +211.82% |
| 2018-03-31 | Rs582.36 Million ≈ $6.30 Million |
Rs108.83 Million ≈ $1.18 Million |
0.187x | -74.93% |
| 2017-03-31 | Rs421.01 Million ≈ $4.55 Million |
Rs313.81 Million ≈ $3.39 Million |
0.745x | +1938.60% |
| 2016-03-31 | Rs491.54 Million ≈ $5.32 Million |
Rs-19.93 Million ≈ $-215.50K |
-0.041x | -107.11% |
| 2015-03-31 | Rs465.71 Million ≈ $5.04 Million |
Rs265.40 Million ≈ $2.87 Million |
0.570x | -64.17% |
| 2014-03-31 | Rs560.17 Million ≈ $6.06 Million |
Rs890.99 Million ≈ $9.64 Million |
1.591x | +914.04% |
| 2013-03-31 | Rs697.62 Million ≈ $7.54 Million |
Rs109.43 Million ≈ $1.18 Million |
0.157x | +154.43% |
| 2012-03-31 | Rs755.73 Million ≈ $8.17 Million |
Rs-217.78 Million ≈ $-2.36 Million |
-0.288x | -380.89% |
| 2010-03-31 | Rs1.43 Billion ≈ $15.41 Million |
Rs146.23 Million ≈ $1.58 Million |
0.103x | +129.68% |
| 2008-03-31 | Rs780.73 Million ≈ $8.44 Million |
Rs-269.87 Million ≈ $-2.92 Million |
-0.346x | -33.00% |
| 2007-03-31 | Rs460.74 Million ≈ $4.98 Million |
Rs-119.75 Million ≈ $-1.29 Million |
-0.260x | -136.00% |
| 2005-03-31 | Rs286.25 Million ≈ $3.10 Million |
Rs206.68 Million ≈ $2.24 Million |
0.722x | -- |
About Lyka Labs Limited
Lyka Labs Limited, a pharmaceutical company, develops, manufactures, and markets pharmaceutical formulations and active pharmaceutical ingredients in India. The company manufactures and sells various formulations, including emollient, topical steroid, antifungal agent, topical anti-bacterial, acne management, dermatological formulation, pain killer, anti-aging, cleansing lotion, hair care, anti-d… Read more